Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status.
Saved in:
| Title: | Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status. |
|---|---|
| Authors: | Førde D; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Kilvær T; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Pedersen MI; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Lombardi AP; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway., D'arsiè I; Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy., Paulsen EE; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Busund LR; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway., Rakaee M; Translational Cancer Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway.; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway., Dønnem T; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Andersen S; Translational Cancer Research Group, Institute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Department of Oncology, University Hospital of North Norway, Tromsø, Norway. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Sep 25; Vol. 15, pp. 1606933. Date of Electronic Publication: 2025 Sep 25 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1606933 |
